Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.
Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
A plain-language reading has not been prepared for this paper yet.
Original abstract
INTRODUCTION: This report presents Parkinson disease mortality for adults age 65 and older by sex, age group, race and Hispanic origin, and state of residence. Trends in Parkinson disease death rates from 2014 through 2024 are also presented. METHODS: Estimates in this report are based on the National Vital Statistics System mortality files, accessed via CDC WONDER. Parkinson disease deaths are identified using the International Classification of Diseases, 10th Revision underlying cause-of-death codes G20 (Parkinson disease) and G21 (Secondary parkinsonism). Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population. Pairwise comparisons of rates were conducted using a z test and trends in death rates were evaluated using the Joinpoint Regression Program (Version 5.0.2). Tests for statistical significance were set with an alpha level of 0.05. KEY FINDINGS: In 2024, the age-adjusted Parkinson disease death rate for adults age 65 and older was 72.0 deaths per 100,000 standard population. Parkinson disease death rates increased from 2014 (57.2) through 2021 (76.3), but the rate in 2024 was lower than in 2021. Death rates from Parkinson disease were higher for men and highest among non-Hispanic White adults age 65 and older compared with other race and Hispanic-origin groups.